Cargando…

Smoking Cessation Advisory Intervention in Patients with Cardiovascular Disease

INTRODUCTION: Several studies have examined the efficacy of smoking cessation therapies in the general population. However little is known about the efficacy of these advisory methods in cardiovascular patients. AIM: The aim of the study is to determine the prevalence and the characteristics of smok...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogiatzis, Ioannis, Pantzartzidou, Alexandra, Pittas, Sarantis, Papavasiliou, Eleutherios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVICENA, d.o.o., Sarajevo 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511535/
https://www.ncbi.nlm.nih.gov/pubmed/28790545
http://dx.doi.org/10.5455/medarh.2017.71.128-131
_version_ 1783250361361891328
author Vogiatzis, Ioannis
Pantzartzidou, Alexandra
Pittas, Sarantis
Papavasiliou, Eleutherios
author_facet Vogiatzis, Ioannis
Pantzartzidou, Alexandra
Pittas, Sarantis
Papavasiliou, Eleutherios
author_sort Vogiatzis, Ioannis
collection PubMed
description INTRODUCTION: Several studies have examined the efficacy of smoking cessation therapies in the general population. However little is known about the efficacy of these advisory methods in cardiovascular patients. AIM: The aim of the study is to determine the prevalence and the characteristics of smoking abstinence in cardiovascular patients, after a smoking intervention during hospitalization. METHODS: The study involved 442 patients, smokers admitted for cardiovascular disease to the Department of Cardiology. During hospitalization patient’s data were collected and all patients were subjected to a 30-minutes long advisory session with drug administration in selected cases (varenicycline, bupropione, nocitine replacement therapy), according to standard protocol. After the discharge patients were asked about smoking abstinence at time intervals of 24 hours, 1 month, 3, 6 and 12 months. RESULTS: After hospital discharge 11 patients (2.49%) could not be contacted after several attempts and 19 patients (4.3%) were died during follow up period. A total of 412 patients (218 men and 194 women, mean age 56.49+10.57 years) made up the final study population. Twenty four hours after hospital discharge 364 patients (88.35%) had quitted smoking. At 1, 3, 6 and 12 months the abstinence rates were 70.87%, 64.8%, 55.82% and 47.83% respectively. Patients with ischaemic cardiovascular diseases (angina – infarction) had a significantly higher probability of quitting smoking at 12 months (Hazard ratio: 0.64 – p=0.01). CONCLUSION: A smoking cessation program in cardiovascular patients during hospitalization was unlikely to result in success. These patients might benefit by following programs promoting smoking cessation in experienced specialized centers, involving a group of health professionals, such as psychologists and/or trained nurses.
format Online
Article
Text
id pubmed-5511535
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher AVICENA, d.o.o., Sarajevo
record_format MEDLINE/PubMed
spelling pubmed-55115352017-08-08 Smoking Cessation Advisory Intervention in Patients with Cardiovascular Disease Vogiatzis, Ioannis Pantzartzidou, Alexandra Pittas, Sarantis Papavasiliou, Eleutherios Med Arch Original Paper INTRODUCTION: Several studies have examined the efficacy of smoking cessation therapies in the general population. However little is known about the efficacy of these advisory methods in cardiovascular patients. AIM: The aim of the study is to determine the prevalence and the characteristics of smoking abstinence in cardiovascular patients, after a smoking intervention during hospitalization. METHODS: The study involved 442 patients, smokers admitted for cardiovascular disease to the Department of Cardiology. During hospitalization patient’s data were collected and all patients were subjected to a 30-minutes long advisory session with drug administration in selected cases (varenicycline, bupropione, nocitine replacement therapy), according to standard protocol. After the discharge patients were asked about smoking abstinence at time intervals of 24 hours, 1 month, 3, 6 and 12 months. RESULTS: After hospital discharge 11 patients (2.49%) could not be contacted after several attempts and 19 patients (4.3%) were died during follow up period. A total of 412 patients (218 men and 194 women, mean age 56.49+10.57 years) made up the final study population. Twenty four hours after hospital discharge 364 patients (88.35%) had quitted smoking. At 1, 3, 6 and 12 months the abstinence rates were 70.87%, 64.8%, 55.82% and 47.83% respectively. Patients with ischaemic cardiovascular diseases (angina – infarction) had a significantly higher probability of quitting smoking at 12 months (Hazard ratio: 0.64 – p=0.01). CONCLUSION: A smoking cessation program in cardiovascular patients during hospitalization was unlikely to result in success. These patients might benefit by following programs promoting smoking cessation in experienced specialized centers, involving a group of health professionals, such as psychologists and/or trained nurses. AVICENA, d.o.o., Sarajevo 2017-04 /pmc/articles/PMC5511535/ /pubmed/28790545 http://dx.doi.org/10.5455/medarh.2017.71.128-131 Text en Copyright: © 2017 Ioannis Vogiatzis, Alexandra Pantzartzidou, Sarantis Pittas, Eleutherios Papavasiliou http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Vogiatzis, Ioannis
Pantzartzidou, Alexandra
Pittas, Sarantis
Papavasiliou, Eleutherios
Smoking Cessation Advisory Intervention in Patients with Cardiovascular Disease
title Smoking Cessation Advisory Intervention in Patients with Cardiovascular Disease
title_full Smoking Cessation Advisory Intervention in Patients with Cardiovascular Disease
title_fullStr Smoking Cessation Advisory Intervention in Patients with Cardiovascular Disease
title_full_unstemmed Smoking Cessation Advisory Intervention in Patients with Cardiovascular Disease
title_short Smoking Cessation Advisory Intervention in Patients with Cardiovascular Disease
title_sort smoking cessation advisory intervention in patients with cardiovascular disease
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511535/
https://www.ncbi.nlm.nih.gov/pubmed/28790545
http://dx.doi.org/10.5455/medarh.2017.71.128-131
work_keys_str_mv AT vogiatzisioannis smokingcessationadvisoryinterventioninpatientswithcardiovasculardisease
AT pantzartzidoualexandra smokingcessationadvisoryinterventioninpatientswithcardiovasculardisease
AT pittassarantis smokingcessationadvisoryinterventioninpatientswithcardiovasculardisease
AT papavasilioueleutherios smokingcessationadvisoryinterventioninpatientswithcardiovasculardisease